Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Radiation Oncology (London, England)|April 12, 2011
Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiencyVasileios Askoxylakis, Gunda Millonig, Ute Wirkner, et al.
Plos One|January 7, 2011
A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technologyVasileios Askoxylakis, Regine Garcia-Boy, Shoaib Rana, et al.
Molecules (Basel, Switzerland)|February 16, 2011
Challenges in optimizing a prostate carcinoma binding peptide, identified through the phage display technologyVasileios Askoxylakis, Sabine Zitzmann-Kolbe, Frederic Zoller, et al.
American Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT studyChristos Sachpekidis, Christian Thieke, Vasileios Askoxylakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Preclinical evaluation of the breast cancer cell-binding peptide, p160Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2018
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruptionCostas D Arvanitis, Vasileios Askoxylakis, Yutong Guo, et al.
BMC Cancer|June 17, 2011
Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trialVasileios Askoxylakis, Alexandra D Jensen, Matthias F Häfner, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
NPJ Breast Cancer|January 25, 2019
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancerVasileios Askoxylakis, Gino B Ferraro, Mark Badeaux, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2018
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine greenJessica A Carr, Daniel Franke, Justin R Caram, et al.
Pageof 5